Dr Mark Boyd

Until recently Professor Boyd was an Associate Professor at the Kirby Institute, a consultant physician in HIV Medicine and Infectious Diseases and a Visiting Medical Officer in inner Sydney as well as regional NSW. In July 2016 he was appointed Inaugural Chair of Medicine at the Lyell McEwin Hospital, University of Adelaide. Professor Boyd is an internationally recognised infectious disease expert. He has led project teams in HIV research in Thailand, as well as at the Kirby Institute for infection and immunity at the University of New South Wales. He has had a key role in two major, multicentre, international randomised clinical trials (‘SECOND-LINE’ and ‘Encore1’) sponsored by the Kirby Institute, which have brought changes to the WHO guidelines on the antiretroviral management of HIV infection in adults and adolescents. In 2014 he was awarded the Frank Fenner Award for Advanced Research in Infectious Diseases by the Australasian Society for Infectious Diseases.

Research Interests
Broad interests in the field of HIV/AIDS including the conduct of interventional clinical trials to provide the evidence for its optimal management across high-, middle- and low-income countries. Professor Boyd works with a very broad and engaged network of research collaborators in Asia, Australasia, Europe, Canada, Latin America, and sub-Saharan Africa. Other interests include tuberculosis and in particular HIV/TB co-infection as well as investigation of antiretroviral toxicity and the bioethics of the conduct of research trials. 

Broad Research Areas
HIV - AIDS, Clinical Research, Infectious Diseases, Evidence Based Medicine, Bioethics

Qualifications
BA (Tas), BM, BS, MHID (FUSA), MD (UNSW), FRACP

Society Memberships & Professional Activities
International AIDS Society (IAS), President, Australasian Society for HIV Medicine (ASHM), Australasian Society for Infectious Diseases (ASID), Fellow of the Royal Australasian College of Physicians (RACP), Co-Editor-in-Chief, AIDS Research and Therapy

Specific Research Keywords
Clinical trials, HIV/AIDS, Antiretroviral therapy, Evidence Based Health Care, Access to HIV care, Infectious Diseases